Related Experiment Video
Updated: May 20, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Blood pressure in renal disease: how to accomplish the goal?
Insights
The ACCOMPLISH trial found that benazepril plus amlodipine better protected kidneys and cardiovascular health in hypertensive patients than benazepril plus hydrochlorothiazide. This supports using calcium channel blockers with renin-angiotensin blockers for kidney and heart protection.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- The ACCOMPLISH trial evaluated initial antihypertensive regimens for patients with systolic hypertension.
- It compared benazepril plus amlodipine against benazepril plus hydrochlorothiazide.
Discussion:
- This review examines the ACCOMPLISH trial's renal findings regarding chronic kidney disease progression.
- It assesses the data's validity and its relation to existing evidence on calcium antagonists in renal disease.
Key Insights:
- Initial therapy with benazepril plus amlodipine demonstrated superiority over benazepril plus hydrochlorothiazide.
- This combination effectively reduced chronic kidney disease progression and cardiovascular events in renal patients.
Outlook:
- The findings support calcium channel blockers as a preferred second-line agent when added to renin-angiotensin axis blockers.
- Further research may explore long-term renal and cardiovascular outcomes with this combination therapy.
Abstract:
The Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial showed that initial antihypertensive therapy with benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing progression of chronic kidney disease as well as cardiovascular morbidity and mortality in renal patients. The renal results of the ACCOMPLISH trial strongly support the recommendation of using calcium channel blockers as second antihypertensive agent added to renin-angiotensin axis-blocking drugs. This review discusses the validity of these data and their relationship with the cumulative evidence on the effects of calcium antagonists on renal disease progression.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...
Blood Pressure
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Hypertension V: Nursing Management
